Fact CheckerSign in

NCT06438744Completed

The Role of Thread Embedding Acupuncture for Pain and Quality of Life in Endometriosis Patients

Source: ClinicalTrials.gov · Last updated 6 May 2025

Brief summary (registry, in English)

Endometriosis is a common gynecological problem, with pain as the main problem. Pain can be felt for years, in high intensity, continuous, unpredictable, and disrupts the patient's daily life, thereby reducing the quality of life. Dienogest is a progestin-derived drug, the first line therapy for endometriosis pain. Other therapy options include hormonal, non-hormonal therapy, and surgery, but they have a high risk of side effects and recurrence. In cases of endometriosis, acupuncture has an analgesic effect, modulates hormones and neurotransmitters, strengthens immune cells, and reduces inflammation, therefore improves quality of life. However, the effectiveness of thread embedding acupuncture for endometriosis pain is still rarely published. This research was conducted to determine the effectiveness of thread embedding acupuncture for pain and quality of life in endometriosis patients.

Status (registry)
Completed
Study type
Interventional
Enrollment
10 (actual)
First submitted
27 May 2024
Start date
18 Dec 2023
Primary completion date
25 Jun 2024
Lead sponsor
Universitas Indonesia
NCT number
NCT06438744

What you commit to

  • Study type: Interventional
  • Participants enrolled: 10
  • From 18 Dec 2023 to the primary completion date, 25 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Subjects who received surgical therapy in the last 3 months.
  • Subjects who have been undergoing acupuncture therapy in the last 2 weeks or TEA in the last 6 months.

Other illness

  • Subjects who have wounds, inflammation, infection, lumps, or eczema at the puncture site.
  • Subjects with blood clotting disorders or who are taking blood thinning medication.
  • Have a history of diabetes mellitus, malignancy, psychiatric disorders, keloids, allergies to stainless steel or PDO threads.

Other

  • Pregnant or breastfeeding women.

Who the study is looking for

  • Women aged 18-45 years.
  • Subjects diagnosed with endometriosis from laparoscopy, ultrasound, or histopathology.
  • Subjects experience at least one type of pain including pelvic pain, dysmenorrhoea, dyspareunia, dyschezia, or dysuria with a minimum NRS score of 4.
  • The subject has undergone endometriosis therapy with dienogest for at least 1 month but the NRS score is still ≥4.
  • Subjects are willing to follow research procedures and sign the informed consent form.

Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cipto Mangunkusumo Hospital
Coordinator of this site? Confirm its status
Jakarta PusatIndonesiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.